Dysfunction at the FDA, NIH, Elsewhere | Predictions for 2025
Predictions for this year from Perry Cohen, Pharm.D., CEO of the TPG Family of Companies and Managed Healthcare Executive editorial advisory board member.
The government’s role in impacting healthcare will be huge in 2025. The Trump administration’s primary objective is focused on undoing the work of previous administrations. They will disrupt healthcare delivery and financing by having people in leadership positions driven by politics and ideology who are not knowledgeable about and committed to the importance of evidence-based science and equitable social policy in advancing and regulating healthcare. HHS, the CDC, the FDA and the National Institutes of Health will lose considerable expertise and become dysfunctional.
Cohen
Access to healthcare will decrease due to undermining or eliminating the Affordable Care Act (ACA). Decreased funding for Medicaid will mean tighter requirements for enrollees. The tightening will be more severe in red states.
Quality of healthcare will decrease due to political and ideology-driven policy at both the federal and state levels due to the changes in Congress and at HHS and the impact of the Supreme Court’s Chevron decision. The out-of-pocket cost of healthcare will skyrocket for patients due to reductions in the ACA, Medicaid and cheap versions of health insurance with limited coverage. Medicare will prioritize Medicare Advantage plans over fee-for-service care, and for-profit healthcare companies will be the beneficiary.
Healthcare hasn't been a priority of the second Trump administration so far, panelists at the Asembia agreed. Medicaid may loom large, though, as the administration and congressional Republicans look for ways to slash government spending as a way of offsetting major tax cuts.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Survey: What Patients and Providers Are Thinking About Healthcare Access
April 28th 2025Patients and providers found common ground on the importance of correct billing estimates but did not see eye to eye in terms of digital scheduling tool use, according to a new survey by Experian Health.
Read More
